Compositions and methods for inhibiting human host factors required for influenza virus replication
    3.
    发明授权
    Compositions and methods for inhibiting human host factors required for influenza virus replication 有权
    用于抑制流感病毒复制所需的人宿主因子的组合物和方法

    公开(公告)号:US09238815B2

    公开(公告)日:2016-01-19

    申请号:US13514783

    申请日:2010-12-10

    摘要: This application relates to the modulation of host cell factors required for influenza virus replication. The application relates to compounds, including nucleic acid compounds (such as, e.g., small interfering RNAs (siRNAs)) and small molecules, that target human host cell factors involved in influenza virus replication, and the use of such compounds for modulating influenza virus replication and as antiviral agents. The application also relates to methods of treating an influenza virus infection and methods of treating or preventing a symptom or disease associated with influenza virus infection, comprising administering to a subject a composition comprising a compound, such as a nucleic acid compound (e.g., an siRNA) or small molecule, that targets a human host cell factor involved in influenza virus replication.

    摘要翻译: 本申请涉及流感病毒复制所需的宿主细胞因子的调节。 本申请涉及靶向涉及流感病毒复制的人宿主细胞因子的核酸化合物(例如小干扰RNA(siRNA))和小分子,以及使用这些化合物调节流感病毒复制 并作为抗病毒剂。 本申请还涉及治疗流感病毒感染的方法和治疗或预防与流感病毒感染相关的症状或疾病的方法,包括向受试者施用包含化合物(例如核酸化合物(例如siRNA) )或小分子,其靶向涉及流感病毒复制的人宿主细胞因子。

    Compositions and Methods for Inhibiting Human Host Factors Required for Influenza Virus Replication
    5.
    发明申请
    Compositions and Methods for Inhibiting Human Host Factors Required for Influenza Virus Replication 有权
    用于抑制流感病毒复制所需的人宿主因子的组合物和方法

    公开(公告)号:US20130090367A1

    公开(公告)日:2013-04-11

    申请号:US13514783

    申请日:2010-12-10

    IPC分类号: C12N15/113

    摘要: This application relates to the modulation of host cell factors required for influenza virus replication. The application relates to compounds, including nucleic acid compounds (such as, e.g., small interfering RNAs (siRNAs)) and small molecules, that target human host cell factors involved in influenza virus replication, and the use of such compounds for modulating influenza virus replication and as antiviral agents. The application also relates to methods of treating an influenza virus infection and methods of treating or preventing a symptom or disease associated with influenza virus infection, comprising administering to a subject a composition comprising a compound, such as a nucleic acid compound (e.g., an siRNA) or small molecule, that targets a human host cell factor involved in influenza virus replication.

    摘要翻译: 本申请涉及流感病毒复制所需的宿主细胞因子的调节。 本申请涉及靶向涉及流感病毒复制的人宿主细胞因子的核酸化合物(例如小干扰RNA(siRNA))和小分子,以及使用这些化合物调节流感病毒复制 并作为抗病毒剂。 本申请还涉及治疗流感病毒感染的方法和治疗或预防与流感病毒感染相关的症状或疾病的方法,包括向受试者施用包含化合物(例如核酸化合物(例如siRNA) )或小分子,其靶向涉及流感病毒复制的人宿主细胞因子。